Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

[Further definition of the role of COX-2 inhibitors and NSAIDs in patients with nociceptive pain].

Bijlsma JW, Lems WF, van de Laar MA.

Ned Tijdschr Geneeskd. 2007 Apr 7;151(14):795-8. Dutch.

PMID:
17469317
2.

Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?

Savage R.

Drugs Aging. 2005;22(3):185-200. Review.

PMID:
15813652
3.

The use of NSAIDs in rheumatic disorders 2005: a global perspective.

Kean WF, Buchanan WW.

Inflammopharmacology. 2005;13(4):343-70. Review.

PMID:
16354389
4.

Anti-inflammatory drugs in the 21st century.

Rainsford KD.

Subcell Biochem. 2007;42:3-27. Review.

PMID:
17612044
6.

How to advise aspirin use in patients who need NSAIDs.

Sopena F, Lanas A.

Curr Pharm Des. 2007;13(22):2248-60. Review.

PMID:
17691998
7.

Cardiovascular issues of COX-2 inhibitors and NSAIDs.

Wong M, Chowienczyk P, Kirkham B.

Aust Fam Physician. 2005 Nov;34(11):945-8. Review.

8.

[Cardiovascular and gastrointestinal risks associated with selective and non-selective NSAIDs].

van den Bemt BJ, Benraad HB, Rasker JJ.

Ned Tijdschr Geneeskd. 2007 May 12;151(19):1062-7. Review. Dutch.

PMID:
17552414
9.

Update on cyclooxygenase inhibitors: has a third COX isoform entered the fray?

Hersh EV, Lally ET, Moore PA.

Curr Med Res Opin. 2005 Aug;21(8):1217-26. Review.

PMID:
16083531
10.

Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.

Dajani EZ, Islam K.

J Physiol Pharmacol. 2008 Aug;59 Suppl 2:117-33. Review.

11.

Systematic review: coxibs, non-steroidal anti-inflammatory drugs or no cyclooxygenase inhibitors in gastroenterological high-risk patients?

Nielsen OH, Ainsworth M, Csillag C, Rask-Madsen J.

Aliment Pharmacol Ther. 2006 Jan 1;23(1):27-33. Review.

12.

Drug insight: cyclo-oxygenase-2 inhibitors--a critical appraisal.

Hinz B, Renner B, Brune K.

Nat Clin Pract Rheumatol. 2007 Oct;3(10):552-60; quiz 1 p following 589. Review.

PMID:
17906610
13.

Unmet needs in non-steroidal anti-inflammatory drug-induced upper gastrointestinal diseases.

Scheiman JM.

Drugs. 2006;66 Suppl 1:15-21; discussion 29-33. Review.

PMID:
16869344
14.

Cardiovascular complications of non-steroidal anti-inflammatory drugs.

Fosslien E.

Ann Clin Lab Sci. 2005 Autumn;35(4):347-85. Review.

PMID:
16254252
15.

Primer: managing NSAID-induced ulcer complications--balancing gastrointestinal and cardiovascular risks.

Chan FK.

Nat Clin Pract Gastroenterol Hepatol. 2006 Oct;3(10):563-73. Review.

PMID:
17008926
16.

An update on nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors.

Williams GW.

Curr Pain Headache Rep. 2005 Dec;9(6):377-89. Review.

PMID:
16282038
18.

Cyclooxygenase-2 inhibitors: what went wrong?

James MJ, Cleland LG.

Curr Opin Clin Nutr Metab Care. 2006 Mar;9(2):89-94. Review.

PMID:
16477171
19.

COX-2 inhibitors: pharmacological data and adverse effects.

Mattia C, Coluzzi F.

Minerva Anestesiol. 2005 Jul-Aug;71(7-8):461-70. Review.

20.

Drug insight: cyclo-oxygenase 2 inhibitors and cardiovascular risk--where are we now?

Spektor G, Fuster V.

Nat Clin Pract Cardiovasc Med. 2005 Jun;2(6):290-300. Review.

PMID:
16265533

Supplemental Content

Support Center